Skip to main content
. Author manuscript; available in PMC: 2013 Mar 1.
Published in final edited form as: Cancer Lett. 2011 Oct 10;316(1):11–22. doi: 10.1016/j.canlet.2011.10.006

Fig. 2.

Fig. 2

Differential growth inhibition effects of CTS on different prostate cells. Cells were treated with EtOH and CTS (0.5 µM) in the absence or presence of 1 nM DHT. Medium with indicated treatments was refreshed every 2 days (the half-life of CTS is 22.5±1.5 hr, data not shown) for a total of 7 days. A: CTS inhibits the DHT-induced growth of LNCaP cells. B: CTS inhibits the DHT-induced growth of CWR22Rv1 cells. C: No effects of CTS on the growth of AR-negative PC-3 cells. D: No effects of CTS on non-malignant prostate RWPE1 cells. Data represent mean ± SD of three independent experiments with three replicates in each experiment.